Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Roberts, Carly
DOB: 10-DEC-1969 (Age: 56)
Gender: female
Address:
2 Price meadow
LE4 Mitchellborough (United Kingdom)
ID: 9384-259853-9 (ECI)
Report
Date: 11-NOV-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
St Matthews Health & Community Centre
Malabar Road 62-66
LE1 4 Leicester (United Kingdom)
Specimen
Collected: 11-NOV-2023

Hematology

Test 11-NOV-2023 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 10.4 4.0 - 11.0 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 5.3 4.2 - 5.4 10*6/uL
Hemoglobin [Mass/volume] in Blood 12.2 12 - 16 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 49.6 H 36 - 46 %
MCV [Entitic mean volume] in Red Blood Cells by Automated count 90.1 80 - 100 fL
MCH [Entitic mass] by Automated count 31.3 27 - 33 pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count 35.3 32 - 36 g/dL
Erythrocyte [DistWidth] in Blood by Automated count 14.8 H 11.5 - 14.5 %
Platelets [#/volume] in Blood by Automated count 374.2 150 - 450 10*3/uL

Chemistry

Test 11-NOV-2023 Reference Range Unit
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 1435.2 H 0 - 450 pg/mL
Glucose [Mass/volume] in Serum or Plasma 79.0 65 - 99 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 11.3 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 0.8 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.0 8.6 - 10.3 mg/dL
Sodium [Moles/volume] in Serum or Plasma 143.2 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 5.2 H 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 106.8 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 20.2 L 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 7.8 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.2 3.5 - 5.2 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 1.1 0.1 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 105.2 H 32 - 91 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 32.3 7 - 56 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19.1 10 - 40 U/L
Magnesium [Mass/volume] in Serum or Plasma 1.7 1.7 - 2.2 mg/dL
Cholesterol [Mass/volume] in Serum or Plasma 145.7 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 147.4 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 86.8 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 29.5 L 40 - 60 mg/dL
Hemoglobin A1c/Hemoglobin.total in Blood 5.1 4.0 - 5.6 %
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 0.0 0.0 - 19.9 pg/mL
Ferritin [Mass/volume] in Serum or Plasma 62.5 13 - 150 ug/L
Iron [Mass/volume] in Serum or Plasma 161.3 50 - 170 ug/dL
Iron binding capacity [Mass/volume] in Serum or Plasma 397.9 250 - 450 ug/dL
Iron saturation [Mass Fraction] in Serum or Plasma 20.0 15 - 50 %

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows markedly elevated NT-proBNP, suggestive of possible heart failure or significant cardiac strain. Mildly high hematocrit, red cell distribution width, potassium, and alkaline phosphatase are noted. Low HDL cholesterol and low total CO₂ may indicate increased cardiovascular risk and possible metabolic acidosis. Other parameters, including renal and liver function, are within normal limits. Clinical correlation and further cardiac evaluation are recommended.